Drugs / CP4071
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00017446 | Oct 2000 → ? | sarcoma | Herbert Irving Comprehensive Cancer Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CP4071 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00017446 ↗ |
| Route | Oral | “Patients receive oral CP4071 daily.” NCT00017446 ↗ |